Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Headquartered in Seoul, South Korea, NatureCell Co.,Ltd. operates globally, manufacturing and distributing a diverse range of products alongside specialized services. The company's consumer goods portfolio includes canned and health-enhancing functional foods, various beverages such as fruit, aloe vera, coffee, and energy drinks, as well as Korean sauces. They also produce cosmetics and are involved in the stem cell product market. These offerings are marketed under both the SAMMI brand and through OEM agreements. Furthermore, NatureCell provides expert services for the cryopreservation of blood cells, specifically endothelial progenitor cells, mononuclear cells, and platelet-rich plasma products. Established in 1960, the company was formerly known as RNL Sammi CO., Ltd. before adopting its current name, NatureCell Co.,Ltd., in April 2013.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.